Analytical Ultracentrifugation for Characterization of Recombinant Viral Particles
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 5 of these applications claim priority to application PCT/US2016/013947, filed Jan 19, 2016. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,429,288 | Analytical Ultracentrifugation for Characterization of Recombinant Viral Particles In force · High confidence UsedRemaining | Genzyme Corporation | In force | High confidence | ||
| US 11,639,887 | Analytical Ultracentrifugation for Characterization of Recombinant Viral Particles In force · High confidence | Genzyme Corporation | In force | High confidence | ||
| US 12,013,326 | Analytical Ultracentrifugation for Characterization of Recombinant Viral Particles In force · Medium confidence | Genzyme Corporation | In force | Medium confidence | ||
| US 12,031,894 | Analytical Ultracentrifugation for Characterization of Recombinant Viral Particles In force · Medium confidence | Genzyme Corporation | In force | Medium confidence | ||
| US 12,085,494 | Analytical Ultracentrifugation for Characterization of Recombinant Viral Particles In force · Medium confidence | Genzyme Corporation | In force | Medium confidence | ||
| US 11,267,924 | Crosslinked Polydiallymine Copolymers for the Treatment of Type 2 Diabetes Lapsed Mar 8, 2026 on the fee record High confidence | Genzyme Corporation | Lapsed Mar 8, 2026 on the fee record | High confidence | ||
| Application 15/325,290 | Main Chain Polyamines Abandoned Abandoned Oct 22, 2018 | Genzyme Corporation | Abandoned | Abandoned Oct 22, 2018 | ||
| Application 15/508,738 | CYCLIC UREA COMPOUNDS AS TROPOMYOSIN-RELATED KINASE (TRK) iNHIBITORS Abandoned Abandoned Dec 4, 2018 | Genzyme Corporation | Abandoned | Abandoned Dec 4, 2018 | ||
| Application 18/797,302 | Analytical Ultracentrifugation for Characterization of Recombinant Viral Particles Pending Not granted | Genzyme Corporation | Pending | Not granted |
9 of 9 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
5 of these are in force and held by Genzyme Corporation.
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.